These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26615376)

  • 1. Intravenous Valproate versus Subcutaneous Sumatriptan in Acute Migraine Attack.
    Ghaderibarmi F; Tavakkoli N; Togha M
    Acta Med Iran; 2015 Oct; 53(10):633-6. PubMed ID: 26615376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered
    Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J
    Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache.
    Edwards KR; Norton J; Behnke M
    Headache; 2001; 41(10):976-80. PubMed ID: 11903525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial.
    Brandes JL; Kudrow D; Stark SR; O'Carroll CP; Adelman JU; O'Donnell FJ; Alexander WJ; Spruill SE; Barrett PS; Lener SE
    JAMA; 2007 Apr; 297(13):1443-54. PubMed ID: 17405970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal sumatriptan for acute treatment of migraineurs with baseline nausea.
    Schulman EA
    Headache; 2012 Feb; 52(2):204-12. PubMed ID: 22229837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMAMIG Study Group.
    Diener HC
    Cephalalgia; 1999 Jul; 19(6):581-8; discussion 542. PubMed ID: 10448545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label trial of a sumatriptan auto-injector for migraine in patients currently treated with subcutaneous sumatriptan.
    Landy SH; Tepper SJ; Wein T; Schweizer E; Ramos E
    Headache; 2013 Jan; 53(1):118-125. PubMed ID: 23148799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized open-label study of sodium valproate vs sumatriptan and metoclopramide for prolonged migraine headache.
    Bakhshayesh B; Seyed Saadat SM; Rezania K; Hatamian H; Hossieninezhad M
    Am J Emerg Med; 2013 Mar; 31(3):540-4. PubMed ID: 23380105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral sumatriptan in the acute treatment of migraine and migraine recurrence in general practice.
    Scott RJ; Aitchison WR; Barker PR; McLaren GI
    QJM; 1996 Aug; 89(8):613-22. PubMed ID: 8935482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group.
    Eur Neurol; 1992; 32(3):177-84. PubMed ID: 1317294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
    Derosier F; Sheftell F; Silberstein S; Cady R; Ruoff G; Krishen A; Peykamian M
    Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sumatriptan. An updated review of its use in migraine.
    Perry CM; Markham A
    Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of subcutaneous sumatriptan in the treatment of recurrence of migraine headache.
    Cull RE; Price WH; Dunbar A
    J Neurol Neurosurg Psychiatry; 1997 May; 62(5):490-5. PubMed ID: 9153607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between Intravenous Sodium Valproate and Subcutaneous Sumatriptan for Treatment of Acute Migraine Attacks; Double-Blind Randomized Clinical Trial.
    Rahimdel A; Mellat A; Zeinali A; Jafari E; Ayatollahi P
    Iran J Med Sci; 2014 Mar; 39(2 Suppl):171-7. PubMed ID: 24753639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
    Winner P; Landy S; Richardson M; Ames M
    Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faster Improvement in Migraine Pain Intensity and Migraine-Related Disability at Early Time Points with AVP-825 (Sumatriptan Nasal Powder Delivery System) versus Oral Sumatriptan: A Comparative Randomized Clinical Trial Across Multiple Attacks from the COMPASS Study.
    Lipton RB; McGinley JS; Shulman KJ; Wirth RJ; Buse DC
    Headache; 2017 Nov; 57(10):1570-1582. PubMed ID: 28880380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine.
    Munjal S; Brand-Schieber E; Allenby K; Spierings ELH; Cady RK; Rapoport AM
    J Headache Pain; 2017 Dec; 18(1):31. PubMed ID: 28251391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. The Sumatriptan Auto-Injector Study Group.
    Eur Neurol; 1991; 31(5):323-31. PubMed ID: 1653140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.